ENZY — Enzymatica AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK849.57m
- SEK776.56m
- SEK45.58m
Annual cashflow statement for Enzymatica AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | Interim Report | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.1 | -45.2 | -68.2 | -48.1 | -52.1 |
| Depreciation | |||||
| Non-Cash Items | -0.779 | -1.3 | 7.2 | 0.256 | -1.73 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.84 | 4.05 | -4.43 | 1.01 | -12.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -10.7 | -35.9 | -65.4 | -40.3 | -60.5 |
| Capital Expenditures | -4.84 | -6.13 | -3.72 | -0.73 | -0.393 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -4.84 | -6.13 | -3.72 | -0.73 | -0.393 |
| Financing Cash Flow Items | 0 | -4.21 | -5.7 | 0 | -7.42 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10 | 49.5 | 88.2 | -1.39 | 128 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.3 | 7.6 | 19.1 | -42.3 | 66.8 |